Insider-Transaktionen (12 Monate) ⓘ
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Fondsaktivität (Vorquartalsvergleich) ⓘ
Keine Fondsdaten für dieses Unternehmen vorhanden.
Top-Fondshalter (Stand: 30.09.2025) ⓘ
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfügbar. Stand der gezeigten 13F-Holdings: 30.09.2025. Letztes global veröffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| XTX Topco Ltd | 40.401 | 37.786 | +6,9% | 0 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 30.09.2025 | ✓ | 2 | 0,2 | 0 |
| 30.06.2025 | ✓ | 23 | 8,4 | 3 |
| 31.03.2025 | ✓ | 23 | 11,3 | 5 |
| 31.12.2024 | ✓ | 27 | 10,7 | 5 |
| 30.09.2024 | vorl. | 23 | 11,2 | 6 |
| 30.06.2024 | vorl. | 46 | 14,6 | 37 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| CITADEL ADVISORS LLC | 208.887 | 74.990 |
| DELTEC ASSET MANAGEMENT LLC | 106.057 | 38.074 |
| GTS SECURITIES LLC | 45.163 | 16.214 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 79.305 | 54.000 | +213.4 % | 28.470 |
| HRT FINANCIAL LP | 55.859 | 43.776 | +362.3 % | 20 |
| RENAISSANCE TECHNOLOGIES LLC | 47.100 | 6.900 | +17.2 % | 16.909 |
| XTX Topco Ltd | 37.786 | 2.045 | +5.7 % | 13.565 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 150 | -891.381 | -100.0 % | 54 |
| VANGUARD GROUP INC | 83.926 | -431.161 | -83.7 % | 30.130 |
| Point72 Asset Management, L.P. | 816.923 | -62.010 | -7.1 % | 293.275 |
| BlackRock, Inc. | 1.066 | -41.334 | -97.5 % | 383 |
| GEODE CAPITAL MANAGEMENT, LLC | 130.077 | -6.703 | -4.9 % | 46.703 |
| ACADIAN ASSET MANAGEMENT LLC | 16.430 | -1.403 | -7.9 % | 4 |
| JPMORGAN CHASE & CO | 158 | -38 | -19.4 % | 57 |
| Tower Research Capital LLC (TRC) | 4.741 | -20 | -0.4 % | 1.702 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 14.11.2025 | Point72 Asset Management, L.P. | Passiv (13G/A) | Ausstieg | 0 | -3,80 pp | |
| 14.11.2025 | 72 Investment Holdings, LLC | Passiv (13G/A) | Ausstieg | 0 | -2,50 pp | |
| 14.11.2025 | Steven A. Cohen | Passiv (13G/A) | Ausstieg | 0 | -6,20 pp | |
| 14.11.2025 | Point72 Capital Advisors, Inc. | Passiv (13G/A) | Ausstieg | 0 | -3,80 pp | |
| 14.11.2025 | Differentiated Ventures Investments, LLC | Passiv (13G/A) | Ausstieg | 0 | -2,50 pp | |
| 14.11.2025 | Point72 Biotech Private Investments, LLC | Passiv (13G/A) | Ausstieg | 0 | -2,50 pp | |
| 12.08.2025 | Versant Ventures V, LLC | Aktivist (13D/A) | Ausstieg | 0 | -12,50 pp | On June 26, 2025, the Issuer entered into an Agreement and Plan of Merger (the "Merger A… |
| 12.08.2025 | Versant Affiliates Fund V, L.P. | Aktivist (13D/A) | Ausstieg | 0 | -0,40 pp | On June 26, 2025, the Issuer entered into an Agreement and Plan of Merger (the "Merger A… |
| 12.08.2025 | Versant Ophthalmic Affiliates Fund I, L.P. | Aktivist (13D/A) | Ausstieg | 0 | -0,40 pp | On June 26, 2025, the Issuer entered into an Agreement and Plan of Merger (the "Merger A… |
| 12.08.2025 | Versant Vantage II GP-GP, LLC | Aktivist (13D/A) | Ausstieg | 0 | -1,20 pp | On June 26, 2025, the Issuer entered into an Agreement and Plan of Merger (the "Merger A… |
| 12.08.2025 | Versant Vantage II GP, L.P. | Aktivist (13D/A) | Ausstieg | 0 | -1,20 pp | On June 26, 2025, the Issuer entered into an Agreement and Plan of Merger (the "Merger A… |
| 12.08.2025 | Versant Vantage II, L.P. | Aktivist (13D/A) | Ausstieg | 0 | -1,20 pp | On June 26, 2025, the Issuer entered into an Agreement and Plan of Merger (the "Merger A… |
| 12.08.2025 | Versant Venture Capital V (Canada) LP | Aktivist (13D/A) | Ausstieg | 0 | -0,90 pp | On June 26, 2025, the Issuer entered into an Agreement and Plan of Merger (the "Merger A… |
| 12.08.2025 | Versant Venture Capital V, L.P. | Aktivist (13D/A) | Ausstieg | 0 | -11,80 pp | On June 26, 2025, the Issuer entered into an Agreement and Plan of Merger (the "Merger A… |
| 12.08.2025 | Versant Ventures V (Canada), L.P. | Aktivist (13D/A) | Ausstieg | 0 | -0,90 pp | On June 26, 2025, the Issuer entered into an Agreement and Plan of Merger (the "Merger A… |
| 12.08.2025 | Versant Ventures V GP-GP (Canada), Inc. | Aktivist (13D/A) | Ausstieg | 0 | -0,90 pp | On June 26, 2025, the Issuer entered into an Agreement and Plan of Merger (the "Merger A… |
| 12.05.2025 | FMR LLC | Passiv (13G/A) | 4,90 % | 1.133.987 | Neu | |
| 12.05.2025 | Abigail P. Johnson | Passiv (13G/A) | 4,90 % | 1.133.987 | Neu | |
| 31.05.2024 | Timothy J. Langer | Passiv (13G/A) | 4,30 % | 993.607 | Neu | |
| 18.03.2024 | Timothy J. Langer | Passiv (13G) | 5,60 % | 1.293.220 | Neu | |
| 03.08.2023 | Versant Ophthalmic Affiliates Fund I, L.P. | Aktivist (13D) | 0,40 % | 90.888 | Neu | |
| 03.08.2023 | Versant Venture Capital V, L.P. | Aktivist (13D) | 11,80 % | 2.726.322 | Neu | |
| 03.08.2023 | Versant Vantage II GP-GP, LLC | Aktivist (13D) | 1,20 % | 274.990 | Neu | |
| 03.08.2023 | Versant Vantage II GP, L.P. | Aktivist (13D) | 1,20 % | 274.990 | Neu | |
| 03.08.2023 | Versant Ventures V (Canada), L.P. | Aktivist (13D) | 0,90 % | 207.486 | Neu | |
| 03.08.2023 | Versant Vantage II, L.P. | Aktivist (13D) | 1,20 % | 274.990 | Neu | |
| 03.08.2023 | Versant Ventures V, LLC | Aktivist (13D) | 12,50 % | 2.899.216 | Neu | |
| 03.08.2023 | Versant Venture Capital V (Canada) LP | Aktivist (13D) | 0,90 % | 207.486 | Neu | |
| 03.08.2023 | Versant Ventures V GP-GP (Canada), Inc. | Aktivist (13D) | 0,90 % | 207.486 | Neu | |
| 03.08.2023 | Versant Affiliates Fund V, L.P. | Aktivist (13D) | 0,40 % | 82.006 | Neu | |
| 27.07.2023 | Point72 Asset Management, L.P. | Passiv (13G) | 3,80 % | 833.333 | Neu | |
| 27.07.2023 | 72 Investment Holdings, LLC | Passiv (13G) | 2,50 % | 549.981 | Neu | |
| 27.07.2023 | Point72 Capital Advisors, Inc. | Passiv (13G) | 3,80 % | 833.333 | Neu | |
| 27.07.2023 | Differentiated Ventures Investments, LLC | Passiv (13G) | 2,50 % | 549.981 | Neu | |
| 27.07.2023 | Point72 Biotech Private Investments, LLC | Passiv (13G) | 2,50 % | 549.981 | Neu | |
| 27.07.2023 | Steven A. Cohen | Passiv (13G) | 6,20 % | 1.383.314 | Neu | |
| 24.07.2023 | OrbiMed Advisors LLC | Aktivist (13D) | 13,40 % | 3.099.265 | Neu | |
| 24.07.2023 | OrbiMed Capital GP VI LLC | Aktivist (13D) | 13,40 % | 3.099.265 | Neu |
Stammdaten
Unternehmen & Branche
| Name | Turnstone Biologics Corp. |
|---|---|
| Ticker | |
| CIK | 0001764974 |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | – |
Externe Quelle: SEC EDGAR »
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 08.08.2025 | 10-Q | 30.06.2025 | 39 Tage | SEC » |
| 09.05.2025 | 10-Q | 31.03.2025 | 39 Tage | SEC » |
| 31.03.2025 | 10-K | 31.12.2024 | 90 Tage | SEC » |
| 12.11.2024 | 10-Q | 30.09.2024 | 43 Tage | SEC » |
| 14.08.2024 | 10-Q | 30.06.2024 | 45 Tage | SEC » |
| 13.05.2024 | 10-Q | 31.03.2024 | 43 Tage | SEC » |
| 22.03.2024 | 10-K | 31.12.2023 | 82 Tage | SEC » |
| 13.11.2023 | 10-Q | 30.09.2023 | 44 Tage | SEC » |
| 01.09.2023 | 10-Q | 30.06.2023 | 63 Tage | SEC » |